Specialised advisory for healthcare companies in Spain

Spain’s healthcare sector comprises more than 163,833 active companies and employs approximately 1,338,891 workers registered with Social Security, making it one of the structural pillars of the national economy. With aggregate revenues exceeding €39.4 billion and a gross margin of 21.8%, the sector combines sustained demand with growing regulatory pressure: consolidation of the private clinic segment through mergers and acquisitions, the emergence of biotech and molecular diagnostics companies, the rise of telemedicine and the changes introduced by the new European Medical Device Regulation are reshaping a competitive landscape at speed. At the same time, NHS pricing and reimbursement rules, clinical trial regulation and health data privacy obligations create a compliance burden that no organisation can face without specialist advisory.

At BMC we accompany pharmaceutical laboratories, biotech and diagnostics companies, medical device manufacturers, private clinics and hospital groups across their tax, legal and corporate advisory needs. Our services include structuring corporate transactions in the sector — mergers, acquisitions, joint ventures — specialist due diligence on healthcare assets, R&D tax planning and comprehensive grant management for biomedical research projects with the CDTI, the Instituto de Salud Carlos III and Horizon Europe.

Intellectual property protection — pharmaceutical patents, supplementary protection certificates, data exclusivity — is a critical area where we combine legal and tax advisory to maximise the value of intangible assets. We assist groups with centralised R&D in documenting transfer pricing policies and applying the Spanish Patent Box regime, and we help organisations across the sector comply with health data protection rules — GDPR applied to medical records and biometric data — and structure their licence and technology transfer agreements with Spanish universities and research centres on sound legal footing.

The broad business fabric of the sector — 163,833 companies, ranging from large hospital groups to single-site diagnostic centres — coexists with considerable variation in management maturity. At BMC we work with both listed groups requiring sophisticated corporate advisory and independent clinics seeking to optimise their tax and employment structure, secure regulatory compliance and grow in an orderly manner. The depth of our team’s sector knowledge means we anticipate problems before they become liabilities.